Serological Monitoring as an Indicator of Population Immunity against Hepatitis B in the Population of the Russian Federation

Hepatitis B (HB) remains one of the serious medical and social health problems, and to assess the epidemiological situation, it is necessary to analyze the state of population immunity by collecting information on its intensity during serological studies. The aim of the work is to assess the level o...

Full description

Saved in:
Bibliographic Details
Main Authors: D. V. Solov’yov, M. I. Korabel’nikova, E. N. Kudryavtceva, N. V. Vlasenko, Y. V. Panasyuk, Z. S. Rodionova, V. V. Klushkina, D. V. Dubodelov, V. M. Glinenko, T. A. Semenenko, S. N. Kuzin, V. G. Akimkin
Format: Article
Language:Russian
Published: Numikom LLC 2024-11-01
Series:Эпидемиология и вакцинопрофилактика
Subjects:
Online Access:https://www.epidemvac.ru/jour/article/view/2080
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849411570478612480
author D. V. Solov’yov
M. I. Korabel’nikova
E. N. Kudryavtceva
N. V. Vlasenko
Y. V. Panasyuk
Z. S. Rodionova
V. V. Klushkina
D. V. Dubodelov
V. M. Glinenko
T. A. Semenenko
S. N. Kuzin
V. G. Akimkin
author_facet D. V. Solov’yov
M. I. Korabel’nikova
E. N. Kudryavtceva
N. V. Vlasenko
Y. V. Panasyuk
Z. S. Rodionova
V. V. Klushkina
D. V. Dubodelov
V. M. Glinenko
T. A. Semenenko
S. N. Kuzin
V. G. Akimkin
author_sort D. V. Solov’yov
collection DOAJ
description Hepatitis B (HB) remains one of the serious medical and social health problems, and to assess the epidemiological situation, it is necessary to analyze the state of population immunity by collecting information on its intensity during serological studies. The aim of the work is to assess the level of population immunity against HB in the population of the Russian Federation in 2017 to 2022. Materials and methods. The results of serological monitoring for the presence of anti-HBs, provided by territorial laboratories of medical institutions of each subject of the Russian Federation in 2017 to 2022, were analyzed. The cohort of subjects in each subject of the Russian Federation consisted of persons in the age groups 3–4, 16–17, 20–29, 30–39, 40–49 years old, numbering at least 100 people each. The analysis of the obtained data for 6 years (2017–2022) was carried out using averaged data for every two years – 2017–2018, 2019–2020 and 2021–2022. The number of study cohorts during these time intervals was 88,151, 84,166 and 97,274 people, respectively. Results and discussion. The average values of the proportion of persons with immunity against HB were 69.0% in 2017–2018, 66.2% in 2019-2020 and 61.3% in 2021–2022. The highest proportion of people with protective immunity against hepatitis B was observed in the age group of 20-29 years. The proportion of children 3-4 years old who had anti-HBs detected at a concentration exceeding 10 IU/l was 65.8–72.5%, and 16–17 years old – 49.6–64.9%. The intensity of post-vaccination immunity against HB in children 16-17 years old should be considered insufficient. Conclusion. An analysis of serological studies results for the period from 2017 to 2022 showed that the potential of vaccine prevention of hepatitis B, carried out since 2006 within the framework of the priority National Project «Health», is not fully realized.
format Article
id doaj-art-64caa671572047bf8a3f607840f79b73
institution Kabale University
issn 2073-3046
2619-0494
language Russian
publishDate 2024-11-01
publisher Numikom LLC
record_format Article
series Эпидемиология и вакцинопрофилактика
spelling doaj-art-64caa671572047bf8a3f607840f79b732025-08-20T03:34:44ZrusNumikom LLCЭпидемиология и вакцинопрофилактика2073-30462619-04942024-11-01235243210.31631/2073-3046-2024-23-5-24-321065Serological Monitoring as an Indicator of Population Immunity against Hepatitis B in the Population of the Russian FederationD. V. Solov’yov0M. I. Korabel’nikova1E. N. Kudryavtceva2N. V. Vlasenko3Y. V. Panasyuk4Z. S. Rodionova5V. V. Klushkina6D. V. Dubodelov7V. M. Glinenko8T. A. Semenenko9S. N. Kuzin10V. G. Akimkin11Center for Hygiene and Epidemiology in MoscowCentral Research Institute of Epidemiology of RospotrebnadzorCentral Research Institute of Epidemiology of RospotrebnadzorCentral Research Institute of Epidemiology of RospotrebnadzorCentral Research Institute of Epidemiology of RospotrebnadzorCentral Research Institute of Epidemiology of RospotrebnadzorCentral Research Institute of Epidemiology of RospotrebnadzorCentral Research Institute of Epidemiology of RospotrebnadzorCenter for Hygiene and Epidemiology in MoscowNational Research Center of Epidemiology and Microbiology named after N. F. Gamaleya of the Ministry of Health of RussiaCentral Research Institute of Epidemiology of RospotrebnadzorCentral Research Institute of Epidemiology of RospotrebnadzorHepatitis B (HB) remains one of the serious medical and social health problems, and to assess the epidemiological situation, it is necessary to analyze the state of population immunity by collecting information on its intensity during serological studies. The aim of the work is to assess the level of population immunity against HB in the population of the Russian Federation in 2017 to 2022. Materials and methods. The results of serological monitoring for the presence of anti-HBs, provided by territorial laboratories of medical institutions of each subject of the Russian Federation in 2017 to 2022, were analyzed. The cohort of subjects in each subject of the Russian Federation consisted of persons in the age groups 3–4, 16–17, 20–29, 30–39, 40–49 years old, numbering at least 100 people each. The analysis of the obtained data for 6 years (2017–2022) was carried out using averaged data for every two years – 2017–2018, 2019–2020 and 2021–2022. The number of study cohorts during these time intervals was 88,151, 84,166 and 97,274 people, respectively. Results and discussion. The average values of the proportion of persons with immunity against HB were 69.0% in 2017–2018, 66.2% in 2019-2020 and 61.3% in 2021–2022. The highest proportion of people with protective immunity against hepatitis B was observed in the age group of 20-29 years. The proportion of children 3-4 years old who had anti-HBs detected at a concentration exceeding 10 IU/l was 65.8–72.5%, and 16–17 years old – 49.6–64.9%. The intensity of post-vaccination immunity against HB in children 16-17 years old should be considered insufficient. Conclusion. An analysis of serological studies results for the period from 2017 to 2022 showed that the potential of vaccine prevention of hepatitis B, carried out since 2006 within the framework of the priority National Project «Health», is not fully realized.https://www.epidemvac.ru/jour/article/view/2080hepatitis bhepatitis b vaccinationserological monitoringanti-hbspost-vaccination immunityrussian federation no conflict of interest to declare
spellingShingle D. V. Solov’yov
M. I. Korabel’nikova
E. N. Kudryavtceva
N. V. Vlasenko
Y. V. Panasyuk
Z. S. Rodionova
V. V. Klushkina
D. V. Dubodelov
V. M. Glinenko
T. A. Semenenko
S. N. Kuzin
V. G. Akimkin
Serological Monitoring as an Indicator of Population Immunity against Hepatitis B in the Population of the Russian Federation
Эпидемиология и вакцинопрофилактика
hepatitis b
hepatitis b vaccination
serological monitoring
anti-hbs
post-vaccination immunity
russian federation no conflict of interest to declare
title Serological Monitoring as an Indicator of Population Immunity against Hepatitis B in the Population of the Russian Federation
title_full Serological Monitoring as an Indicator of Population Immunity against Hepatitis B in the Population of the Russian Federation
title_fullStr Serological Monitoring as an Indicator of Population Immunity against Hepatitis B in the Population of the Russian Federation
title_full_unstemmed Serological Monitoring as an Indicator of Population Immunity against Hepatitis B in the Population of the Russian Federation
title_short Serological Monitoring as an Indicator of Population Immunity against Hepatitis B in the Population of the Russian Federation
title_sort serological monitoring as an indicator of population immunity against hepatitis b in the population of the russian federation
topic hepatitis b
hepatitis b vaccination
serological monitoring
anti-hbs
post-vaccination immunity
russian federation no conflict of interest to declare
url https://www.epidemvac.ru/jour/article/view/2080
work_keys_str_mv AT dvsolovyov serologicalmonitoringasanindicatorofpopulationimmunityagainsthepatitisbinthepopulationoftherussianfederation
AT mikorabelnikova serologicalmonitoringasanindicatorofpopulationimmunityagainsthepatitisbinthepopulationoftherussianfederation
AT enkudryavtceva serologicalmonitoringasanindicatorofpopulationimmunityagainsthepatitisbinthepopulationoftherussianfederation
AT nvvlasenko serologicalmonitoringasanindicatorofpopulationimmunityagainsthepatitisbinthepopulationoftherussianfederation
AT yvpanasyuk serologicalmonitoringasanindicatorofpopulationimmunityagainsthepatitisbinthepopulationoftherussianfederation
AT zsrodionova serologicalmonitoringasanindicatorofpopulationimmunityagainsthepatitisbinthepopulationoftherussianfederation
AT vvklushkina serologicalmonitoringasanindicatorofpopulationimmunityagainsthepatitisbinthepopulationoftherussianfederation
AT dvdubodelov serologicalmonitoringasanindicatorofpopulationimmunityagainsthepatitisbinthepopulationoftherussianfederation
AT vmglinenko serologicalmonitoringasanindicatorofpopulationimmunityagainsthepatitisbinthepopulationoftherussianfederation
AT tasemenenko serologicalmonitoringasanindicatorofpopulationimmunityagainsthepatitisbinthepopulationoftherussianfederation
AT snkuzin serologicalmonitoringasanindicatorofpopulationimmunityagainsthepatitisbinthepopulationoftherussianfederation
AT vgakimkin serologicalmonitoringasanindicatorofpopulationimmunityagainsthepatitisbinthepopulationoftherussianfederation